Additive Solution for the Suspension of Blood Products
NHS Blood and Transplant · £8,000,000 · closes 19 Sept 2023
£8,000,000
Estimated value
Closed
Deadline
14 Aug 2023
Published
This tender has closed.
See what's open in medical equipment and pharmaceuticals, or get contracts like this in your inbox each morning — free.
About this contract
To establish a Framework Agreement with the following Blood Establishments as beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service (SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service (NZBS) and the Irish Blood Transfusion Service (IBTS). Additive Solutions for the Suspension of Blood Products: Lot 1: Additive solution for the suspension of pooled platelets, granulocytes and other components derived from whole blood; Additive solution for the suspension of single donor apheresis derived platelets; Lot 2: SAGM solution for the routine washing and re-suspension of red cells during the production of specialist blood components in accordance with the Guidelines for the Blood Transfusion Services in the UK details of which can be found at the following website https://www.transfusionguidelines.org/red-book Lot 3: Additive Solution for the suspension of washed platelets; Lot 4: Saline 0.9% for the dilution of serum eye drops Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
Key dates
Source
Who to contact
Tender documents
Similar open tenders
Contains public sector information licensed under OGL v3.0